Springer Nature (SPG) Q4 2024 earnings summary

Executive summary

• Achieved strong 2024 results with 5% underlying revenue growth to €1,847 million and 7% adjusted operating profit growth to €512 million, driven by the research segment and supported by technology and AI initiatives.

• Research segment contributed 77% of revenue, growing 6% year-over-year, with 50% of primary research articles published open access, reflecting leadership in OA transition.

• IPO completed six months ago, with proceeds used to reduce leverage and support growth.

• Continued investment in technology and AI to enhance publishing processes and operational efficiency.

• FY 2025 guidance aligns with mid-term outlook, expecting further margin improvement.

Financial highlights

• Reported revenue of €1,847 million (+5% underlying), adjusted operating profit of €512 million (+7% underlying), and free cash flow of €219 million (+€54 million year-over-year).

• Adjusted operating profit margin expanded by 63 basis points to 28.3%.

• Adjusted EPS increased by €0.52 to €1.09.

• Net result for the period improved to €69 million (from €16 million in 2023).

• Financial leverage ratio reduced to 2.3x, supported by debt repayment and IPO proceeds.

Outlook and guidance

• 2025 revenue guidance set at €1,885–€1,935 million, with adjusted operating profit margin expected at least at 2024 levels.

• Midterm guidance unchanged: margin expansion of one percentage point over three years, with 2025 as the base year.

• Dividend policy targets distribution of around 50% of adjusted net income.